ISSCR News
Member Spotlight: Clive Svendsen, PhD
“I love training new undergrads/techs/post docs/scientists/professors in this exciting field and of course seeing exciting results!”
Access a World of Discovery
ISSCR members now have access to ISSCR.DigitaI, delivering the society’s vast library of on-demand content, live events, and year-round opportunities to make international connections – all in one place.
Researchers Identify Sustainable Source of Immunodeficiency Virus-resistant Immune Cells
Genetic engineering can make immune cells resistant to infection with human or monkey (simian) immunodeficiency virus (HIV and SIV, respectively). Recently, treatment with HIV-resistant immune cells has given encouraging results in patients. Stem cell researchers have now found ways of making large numbers of virus-resistant immune cells from monkeys, allowing future studies on safety and efficacy of immune therapy in a pre-clinical animal model. This encouraging research, recently published in Stem Cell Reports, will help scientists consider alternative approaches to treating HIV, the virus causing AIDS.
The ISSCR Announces the Election of New Officers and Members of the Board of Directors
Skokie, IL – The International Society for Stem Cell Research (ISSCR) is pleased to announce the results of its 2022 election. Valentina Greco, PhD, Carolyn Walch Slayman Professor and Vice-chair of Diversity, Equity, and Inclusion in the Genetics Department, Yale School of Medicine, USA will become the next Vice President. Clive Svendsen, PhD, Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine and Executive Director of the Board of Governors Regenerative Medicine Institute at Cedars-Sinai Medical Center in Los Angeles, USA was elected Treasurer.
The Future Is Now
We’ve seen some extraordinary stem cell advances reaching the clinic. A recent clinical trial could have a significant impact on patients with Type 1 diabetes. Advances in cell therapy for the treatment of Parkinson’s disease, and a stem cell-derived model that has enabled researchers to identify drug candidates that may slow dry age-related macular degeneration (AMD). These are only a few of the potential ways stem cell science is positioned to make significant impact on the treatment of devastating diseases.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .